Overcoming potential barriers to investigating and treating myxomatous mitral valve disease

Achieving a diagnosis of mitral valve disease (MMVD) can be relatively straightforward. Persuading owners to investigate and treat, and then maintaining adherence to a therapeutic regimen can be significantly more challenging. While heart murmurs are most likely to be detected during the annual heal...

Full description

Bibliographic Details
Main Author: Belshaw, Zoe
Format: Article
Published: BMJ Publishing Group 2018
Online Access:https://eprints.nottingham.ac.uk/51481/
_version_ 1848798506043572224
author Belshaw, Zoe
author_facet Belshaw, Zoe
author_sort Belshaw, Zoe
building Nottingham Research Data Repository
collection Online Access
description Achieving a diagnosis of mitral valve disease (MMVD) can be relatively straightforward. Persuading owners to investigate and treat, and then maintaining adherence to a therapeutic regimen can be significantly more challenging. While heart murmurs are most likely to be detected during the annual health check or booster consultation, recent evidence suggests this might not be an ideal time to discuss MMVD. This article reviews some of the potential barriers to owners following practitioners’ recommendations, and suggests some solutions.
first_indexed 2025-11-14T20:20:51Z
format Article
id nottingham-51481
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T20:20:51Z
publishDate 2018
publisher BMJ Publishing Group
recordtype eprints
repository_type Digital Repository
spelling nottingham-514812020-05-04T19:52:03Z https://eprints.nottingham.ac.uk/51481/ Overcoming potential barriers to investigating and treating myxomatous mitral valve disease Belshaw, Zoe Achieving a diagnosis of mitral valve disease (MMVD) can be relatively straightforward. Persuading owners to investigate and treat, and then maintaining adherence to a therapeutic regimen can be significantly more challenging. While heart murmurs are most likely to be detected during the annual health check or booster consultation, recent evidence suggests this might not be an ideal time to discuss MMVD. This article reviews some of the potential barriers to owners following practitioners’ recommendations, and suggests some solutions. BMJ Publishing Group 2018-03 Article PeerReviewed Belshaw, Zoe (2018) Overcoming potential barriers to investigating and treating myxomatous mitral valve disease. In Practice, 40 (Suppl). pp. 16-19. ISSN 0263-841X https://doi.org/10.1136/inp.k916 doi:10.1136/inp.k916 doi:10.1136/inp.k916
spellingShingle Belshaw, Zoe
Overcoming potential barriers to investigating and treating myxomatous mitral valve disease
title Overcoming potential barriers to investigating and treating myxomatous mitral valve disease
title_full Overcoming potential barriers to investigating and treating myxomatous mitral valve disease
title_fullStr Overcoming potential barriers to investigating and treating myxomatous mitral valve disease
title_full_unstemmed Overcoming potential barriers to investigating and treating myxomatous mitral valve disease
title_short Overcoming potential barriers to investigating and treating myxomatous mitral valve disease
title_sort overcoming potential barriers to investigating and treating myxomatous mitral valve disease
url https://eprints.nottingham.ac.uk/51481/
https://eprints.nottingham.ac.uk/51481/
https://eprints.nottingham.ac.uk/51481/